Targeting the checkpoint kinase WEE1 Selective sensitization of cancer cells to DNA-damaging drugs

被引：22

作者：

Indovina, Paola ^{[1
,2
]}

Giordano, Antonio ^{[1
,2
,3
]}

机构：

[1] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy

[2] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA

[3] CROM, Avellino, Italy

来源：

CANCER BIOLOGY & THERAPY | 2010年 / 9卷 / 07期

关键词：

WEE1; G(2) checkpoint abrogators; DNA-damaging agents; p53-deficient cancer cells; MK-1775; G(2) CHECKPOINT; MICROSATELLITE INSTABILITY; TUMOR-CELLS; ABROGATION; CHK1; INHIBITOR; THERAPIES; P53;

D O I：

10.4161/cbt.9.7.11276

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：523 / 525

页数：3

共 23 条

[1]

Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions [J].

Bartz, Steven R. ;

Zhang, Zhan ;

Burchard, Julja ;

Imakura, Maki ;

Martin, Melissa ;

Palmieri, Anthony ;

Needham, Rachel ;

Guo, Jie ;

Gordon, Marcia ;

Chung, Namjin ;

Warrener, Paul ;

Jackson, Aimee L. ;

Carleton, Michael ;

Oatley, Melissa ;

Locco, Louis ;

Santini, Francesca ;

Smith, Todd ;

Kunapuli, Priya ;

Ferrer, Marc ;

Strulovici, Berta ;

Friend, Stephen H. ;

Linsley, Peter S. .

MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (24) :9377-9386

[2]

Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1 [J].

Blasina, Alessandra ;

Hallin, Jill ;

Chen, Enhong ;

Arango, Maria Elena ;

Kraynov, Eugenia ;

Grant, Stephan ;

Ninkovic, Sacha ;

Chen, Ping ;

Nichols, Tim ;

O'Connor, Patrick ;

Anderes, Kenna .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) :2394-2404

[3]

Aurora-B phosphorylates histone H3 at serine28 with regard to the mitotic chromosome condensation [J].

Goto, H ;

Yasui, Y ;

Nigg, EA ;

Inagaki, M .

GENES TO CELLS, 2002, 7 (01) :11-17

[4]

Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents [J].

Hirai, Hiroshi ;

Iwasawa, Yoshikazu ;

Okada, Megumu ;

Arai, Tsuyoshi ;

Nishibata, Toshihide ;

Kobayashi, Makiko ;

Kimura, Toshifumi ;

Kaneko, Naoki ;

Ohtani, Junko ;

Yamanaka, Kazunori ;

Itadani, Hiraku ;

Takahashi-Suzuki, Ikuko ;

Fukasawa, Kazuhiro ;

Oki, Hiroko ;

Nambu, Tadahiro ;

Jiang, Jian ;

Sakai, Takumi ;

Arakawa, Hiroharu ;

Sakamoto, Toshihiro ;

Sagara, Takeshi ;

Yoshizumi, Takashi ;

Mizuarai, Shinji ;

Kotani, Hidehito .

MOLECULAR CANCER THERAPEUTICS, 2009, 8 (11) :2992-3000

[5]

HIRAT H, 2010, CANCER BIOL THER, V9, P523

[6]

Kawabe T, 2004, MOL CANCER THER, V3, P513

[7]

MECHANISM BY WHICH CAFFEINE POTENTIATES LETHALITY OF NITROGEN-MUSTARD [J].

LAU, CC ;

PARDEE, AB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (09) :2942-2946

[8]

p53-based cancer therapies: is defective p53 the Achilles heel of the tumor? [J].

Levesque, Aime A. ;

Eastman, Alan .

CARCINOGENESIS, 2007, 28 (01) :13-20

[9]

5-Fluorouracil: Mechanisms of action and clinical strategies [J].

Longley, DB ;

Harkin, DP ;

Johnston, PG .

NATURE REVIEWS CANCER, 2003, 3 (05) :330-338

[10]

Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo [J].

Matthews, David J. ;

Yakes, F. Michael ;

Chen, Jason ;

Tadano, Michele ;

Bornheim, Lester ;

Clary, Douglas O. ;

Tai, Albert ;

Wagner, Jill M. ;

Miller, Nicole ;

Kim, Yong D. ;

Robertson, Scott ;

Murray, Louis ;

Karnitz, Larry M. .

CELL CYCLE, 2007, 6 (01) :104-110

← 1 2 3 →